Better Buy: Veeva Systems or Teladoc?
If you had plunked down $1,000 into either Veeva Systems (NYSE: VEEV) or Teladoc Health (NYSE: TDOC) stock a year ago, you would have more than doubled your money by now. To some, both stocks may now look overpriced compared with their earnings, but that metric can fail to capture potential upside for growth stocks with marked revenue expansion.
Veeva provides cloud-based software for pharmaceutical and life science companies, assisting them in the regulatory process and in sales. Teladoc is the best-known virtual healthcare provider, with its services used by 40% of Fortune 500 companies.
Both companies grew in part this past year because of factors related to the pandemic, but I see more promising growth ahead for Veeva.
Source Fool.com
